Patent · US Active

Identification of tumor-associated markers for diagnosis and therapy

US10253373B2 · kind B2 · utility

1Cited by

4References

5Claims

0Family size

Assignee

BioNTech AG · DE

Inventors

Ugur Sahin · Mainz, DE
Ozlem Tureci · Homburg, DE
Michael Koslowski · Mainz, DE

Key dates

Filing date	May 10, 2017
Grant date	Apr 9, 2019
Priority date	—
Expiry date	May 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present technology relates to genetic products the expression of which is associated with cancer diseases. The present technology also relates to the therapy and diagnosis of diseases in which the genetic products are expressed or aberrantly expressed, in particular cancer diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.